Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis

Background: The lack of effective serum and cerebrospinal fluid (CSF) biomarkers remains a barrier to early diagnosis and treatment of multiple sclerosis (MS). The study is to identify the diagnostic biomarkers of serum and CSF in patients who suffered MS. Methods: At first, we performed differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haijie, Wang, Ziwen, Li, He, Li, Meijie, Han, Bo, Qi, Yuan, Wang, Huailu, Gao, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092947/
https://www.ncbi.nlm.nih.gov/pubmed/35571066
http://dx.doi.org/10.3389/fgene.2022.892491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092947/
https://www.ncbi.nlm.nih.gov/pubmed/35571066
http://dx.doi.org/10.3389/fgene.2022.892491

Ejemplares similares